Table 2 Correlation between clinicopathological characteristics and Lgr5 expression in patients with SCCE

Gender

.601

male

18

15

female

5

6

Age

.241

>60

6

9

<=60

17

12

Tumor length(39 available)

.256

> = 5 cm

9

12

<5 cm

11

7

Tumor location

.721

Upper thoracic segment

3

4

Middle thoracic segment

11

11

Lower thoracic segment

9

6

AJCC stage(43 available)

.003

I/II

15

4

III/IV

8

16

T classification(40 available)

.206

T < =2

12

8

T > 2

8

12

N classification(42 available)

.003

N0

13

3

N+

9

17

M classification(43 available)

.329

M0

19

14

M1

4

6

Chemotherapy response(19 available)

.013

Reached CR/PR

5

1

Did not reach CR/PR

3

10